Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 9418891)

1.

The respiratory chain supercomplex organization is independent of COX7a2l isoforms.

Mourier A, Matic S, Ruzzenente B, Larsson NG, Milenkovic D.

Cell Metab. 2014 Dec 2;20(6):1069-75. doi: 10.1016/j.cmet.2014.11.005.

2.

EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes.

Miyazaki T, Ikeda K, Horie-Inoue K, Kondo T, Takahashi S, Inoue S.

Oncogenesis. 2014 Nov 3;3:e126. doi: 10.1038/oncsis.2014.40.

3.

Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.

Giusti F, Ottanelli S, Masi L, Amedei A, Brandi ML, Falchetti A.

Clin Cases Miner Bone Metab. 2011 Jan;8(1):37-50.

4.

Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.

Stender JD, Kim K, Charn TH, Komm B, Chang KC, Kraus WL, Benner C, Glass CK, Katzenellenbogen BS.

Mol Cell Biol. 2010 Aug;30(16):3943-55. doi: 10.1128/MCB.00118-10. Epub 2010 Jun 14.

5.

Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

Yin P, Lin Z, Reierstad S, Wu J, Ishikawa H, Marsh EE, Innes J, Cheng Y, Pearson K, Coon JS 5th, Kim JJ, Chakravarti D, Bulun SE.

Cancer Res. 2010 Feb 15;70(4):1722-30. doi: 10.1158/0008-5472.CAN-09-2612. Epub 2010 Feb 2.

6.

Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.

Kino T, Chrousos GP.

Mol Interv. 2009 Dec;9(6):294-8. doi: 10.1124/mi.9.6.4. No abstract available.

7.

The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells.

Rüder C, Höpken UE, Wolf J, Mittrücker HW, Engels B, Erdmann B, Wollenzin S, Uckert W, Dörken B, Rehm A.

J Clin Invest. 2009 Aug;119(8):2184-203. doi: 10.1172/JCI37760. Epub 2009 Jul 20.

8.

Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Chen JQ, Brown TR, Russo J.

Biochim Biophys Acta. 2009 Jul;1793(7):1128-43. doi: 10.1016/j.bbamcr.2009.03.009. Epub 2009 Apr 5. Review.

9.

Hormonal regulation of cardiac KCNE2 gene expression.

Kundu P, Ciobotaru A, Foroughi S, Toro L, Stefani E, Eghbali M.

Mol Cell Endocrinol. 2008 Sep 24;292(1-2):50-62. doi: 10.1016/j.mce.2008.06.003. Epub 2008 Jun 19.

10.

Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits.

Ramachandran B, Yu G, Gulick T.

J Biol Chem. 2008 May 2;283(18):11935-46. doi: 10.1074/jbc.M707389200. Epub 2008 Jan 24.

11.

Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

Levy N, Tatomer D, Herber CB, Zhao X, Tang H, Sargeant T, Ball LJ, Summers J, Speed TP, Leitman DC.

Mol Endocrinol. 2008 Feb;22(2):287-303. Epub 2007 Oct 25.

12.

Functional analysis of p53 binding under differential stresses.

Krieg AJ, Hammond EM, Giaccia AJ.

Mol Cell Biol. 2006 Oct;26(19):7030-45.

13.

Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Dowers TS, Qin ZH, Thatcher GR, Bolton JL.

Chem Res Toxicol. 2006 Sep;19(9):1125-37. Review. No abstract available.

14.
15.

Differential gene regulation by the SRC family of coactivators.

Zhang H, Yi X, Sun X, Yin N, Shi B, Wu H, Wang D, Wu G, Shang Y.

Genes Dev. 2004 Jul 15;18(14):1753-65.

16.

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.

Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Inoue S, Okamura K, Sasano H, Yaegashi N.

Br J Cancer. 2004 Jun 1;90(11):2197-202.

17.

EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.

Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H.

Br J Cancer. 2001 Nov 30;85(11):1731-7.

18.

Estrogen receptor interaction with estrogen response elements.

Klinge CM.

Nucleic Acids Res. 2001 Jul 15;29(14):2905-19. Review.

19.

A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16.

Lee N, Daly MJ, Delmonte T, Lander ES, Xu F, Hudson TJ, Mitchell GA, Morin CC, Robinson BH, Rioux JD.

Am J Hum Genet. 2001 Feb;68(2):397-409. Epub 2001 Jan 10.

20.

Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.

Orimo A, Inoue S, Minowa O, Tominaga N, Tomioka Y, Sato M, Kuno J, Hiroi H, Shimizu Y, Suzuki M, Noda T, Muramatsu M.

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12027-32.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk